TEDOPI

Serial Number 97092394
Registration 7870681
700

Registration Progress

Application Filed
Oct 26, 2021
Under Examination
Nov 1, 2022
Approved for Publication
Sep 6, 2022
Published for Opposition
Sep 6, 2022
Registered
Jul 22, 2025

Trademark Image

TEDOPI

Basic Information

Serial Number
97092394
Registration Number
7870681
Filing Date
October 26, 2021
Registration Date
July 22, 2025
Published for Opposition
September 6, 2022
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Jul 22, 2025
Registration
Registered
Classes
005

Rights Holder

OSE Immunotherapeutics

99
Address
22 Boulevard Benoni Goullin
Nantes 44200
FR

Ownership History

OSE Immunotherapeutics

Original Applicant
99
Nantes FR

OSE Immunotherapeutics

Owner at Publication
99
Nantes FR

OSE Immunotherapeutics

Original Registrant
99
Nantes FR

Legal Representation

Attorney
Patrick J. Jennings

USPTO Deadlines

Next Deadline
2042 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20250722)
Due Date
July 22, 2031
Grace Period Ends
January 22, 2032
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

30 events
Date Code Type Description Documents
Jul 22, 2025 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Jul 22, 2025 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jul 16, 2025 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Jul 1, 2025 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Jun 27, 2025 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Oct 28, 2024 IUAF S USE AMENDMENT FILED Loading...
Jun 27, 2025 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Jun 27, 2025 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Nov 25, 2024 EPPA I TEAS POST PUBLICATION AMENDMENT RECEIVED Loading...
Oct 28, 2024 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Apr 30, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 29, 2024 EX3G S SOU EXTENSION 3 GRANTED Loading...
Apr 29, 2024 EXT3 S SOU EXTENSION 3 FILED Loading...
Apr 29, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 28, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 26, 2023 EX2G S SOU EXTENSION 2 GRANTED Loading...
Oct 26, 2023 EXT2 S SOU EXTENSION 2 FILED Loading...
Oct 26, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 2, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 28, 2023 EX1G S SOU EXTENSION 1 GRANTED Loading...
Apr 28, 2023 EXT1 S SOU EXTENSION 1 FILED Loading...
Apr 28, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 1, 2022 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Sep 6, 2022 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Sep 6, 2022 PUBO A PUBLISHED FOR OPPOSITION Loading...
Aug 17, 2022 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Aug 3, 2022 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Aug 3, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Nov 9, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Oct 29, 2021 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical products for cancer treatment, oncology and immunotherapy; Sanitary preparations for medical use; Pharmaceutical products for use in human medicine for cancer treatment, oncology and immunotherapy; Chemical preparations for pharmaceutical or medical purposes, namely, for cancer treatment, oncology and immunotherapy; Vaccines; Medicated serums for cancer treatment, oncology and immunotherapy; Chemical reagents for medical purposes
First Use Anywhere: 20220700
First Use in Commerce: May 24, 2024

Additional Information

Translation
The wording TEDOPI has no meaning in a foreign language.

Classification

International Classes
005